Literature DB >> 734443

Hormone receptors: their role in predicting prognosis and response to endocrine therapy.

W L McGuire.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 734443

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  75 in total

Review 1.  Tissue architecture and breast cancer: the role of extracellular matrix and steroid hormones.

Authors:  R K Hansen; M J Bissell
Journal:  Endocr Relat Cancer       Date:  2000-06       Impact factor: 5.678

2.  Steroid hormone receptor levels and adjuvant tamoxifen in early breast cancer. Ten year results of the Naples (GUN) Study.

Authors:  S De Placido; C Gallo; A Marinelli; F Perrone; C Pagliarulo; G Petrella; G Delrio; M D'Istria; L Del Mastro; A R Bianco
Journal:  Breast Cancer Res Treat       Date:  1990-09       Impact factor: 4.872

3.  Bcl-2 expression and triple negative profile in breast carcinoma.

Authors:  Imen Kallel-Bayoudh; Hanen Ben Hassen; Abdelmajid Khabir; Noureddine Boujelbene; Jamel Daoud; Mounir Frikha; Tahia Sallemi-Boudawara; Sami Aifa; Ahmed Rebaï
Journal:  Med Oncol       Date:  2010-10-02       Impact factor: 3.064

Review 4.  Targeted functional imaging in breast cancer.

Authors:  Rakesh Kumar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-03       Impact factor: 9.236

5.  Influence of tissue heterogeneity on the determination of steroid receptors in breast cancer.

Authors:  H Geyer; M Eberl; B Hornberger
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

Review 6.  Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer.

Authors:  Christa K Baumann; Monica Castiglione-Gertsch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Oncogene amplification in breast cancer.

Authors:  M Donovan-Peluso; A M Contento; H Tobon; B Ripepi; J Locker
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

8.  Estrogen receptor status of breast cancer in Ontario.

Authors:  G E McKeown-Eyssen; I Rogers-Melamed; E A Clarke
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

Review 9.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 10.  Expression profiling of human breast cancers and gene regulation by progesterone receptors.

Authors:  Britta M Jacobsen; Jennifer K Richer; Carol A Sartorius; Kathryn B Horwitz
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.